Phase 3 HIV and AIDS Trial, Recruiting NCT07092930 Sponsor: Poznan University of Physical Education Condition: HIV and AIDS
Back to Hiv Aids

Phase 3 HIV and AIDS Trial, Recruiting

NCT07092930
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have given written agreement to take part in the study
  • People who are in generally good health
  • People who have a current medical clearance from a doctor to practise sports
  • People with at least 4 years of training experience
  • People who complete a minimum of 4 workout sessions per week in the sport or discipline the study focuses on

Who may not be able to join:

  • People who currently have an injury
  • People who have any health condition that would make participation unsafe (confirm with trial site)
  • People who are currently feeling generally unwell
  • People who have taken supplements — particularly performance-enhancing supplements that affect the body's cellular energy capacity — within the 3 months before the study (note: protein powders, carbohydrate powders, and isotonic drinks are exceptions to this rule)
  • People who are unwilling to follow the study's required protocol

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Krzysztof Durkalec-Michalski, PhD, Department of Sports Dietetics, Poznan University of Physical Education Poznań

Phone: +48 66 317 56 06

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Poznan University of Physical Education
Registry
ClinicalTrials.gov
Start date
1 October 2023
Est. completion
1 December 2025

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Changes in anaerobic capacity during Wingate Anaerobic Test (WAnT); Changes in Countermovement Jump (CMJ) performance; Changes in aerobic capacity during incremental cycling test (ICT); Changes in blood bicarbonate, base excess, anion gap, and lactate concentrations; Changes in hydrogen ion concentration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov